Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Avanir's Over-Priced Cough Syrup Touted For Role in Alzheimer's Agitation
TheStreet.com
Monday, September 15, 2014 - 11:37am
tags:
Avanir, Alzheimer's disease, AVP-923
U.S. Hepatitis Problem to Continue Driving These 4 Top Stocks
24/7 Wall St
Monday, September 15, 2014 - 11:36am
tags:
hepatitis C, Gilead Sciences, AbbVie, Achillion, Merck, Sovaldi, Idenix
Roche's Genentech triggers its PhIII program for blockbuster AMD contender
Fierce Biotech
Monday, September 15, 2014 - 10:51am
tags:
Roche, Genentech, AMD, Chroma, Spectri
Shire eating disorder drug gets U.S. priority review
Yahoo/Reuters
Monday, September 15, 2014 - 10:27am
tags:
Shire, binge eating disorder, Vyvanse
EU to decide on $52 bln AbbVie, Shire deal by Oct. 16
Yahoo/Reuters
Monday, September 15, 2014 - 10:24am
tags:
Europe, AbbVie, Shire
Big Pharma: $100 Billion In Future Sales Expected
Bidness Etc.
Monday, September 15, 2014 - 10:10am
tags:
Bristol-Myers Squibb, Merck, GSK, Novo Nordisk, Sanofi, Novartis, Pfizer, Biogen Idec, Roche
Lung cancer vaccine to enter clinical trials
Pharmaphorum
Monday, September 15, 2014 - 10:02am
tags:
lung cancer, vaccines, Asterias, AST-VAC2, non-small cell lung cancer
Amgen Presents Analyses Of Phase 3 Ivabradine Data For The Treatment Of Chronic Heart Failure
Yahoo
Monday, September 15, 2014 - 9:21am
tags:
Amgen, ivabradine, chronic heart failure
Selling Obesity Drugs to Americans Shouldn't Be This Hard
Bloomberg/Businessweek
Monday, September 15, 2014 - 9:18am
tags:
obesity, Orexigen, Contrave, Qsymia, Belviq, Arena Pharmaceuticals, Eisai
Ackman’s Pershing Fund Seeks to Raise $2 Billion in IPO
Bloomberg
Monday, September 15, 2014 - 9:16am
tags:
Bill Ackman, IPOs, Pershing Square, Allergan
Paper Clip-Sized Heart Devices Open New Medtronic Market
Bloomberg
Monday, September 15, 2014 - 8:51am
tags:
Medtronic, devices, Nanostim, Reveal LINQ
Gilead signs pact with 7 firms for cheap copies of hepatitis C drug
Yahoo/Reuters
Monday, September 15, 2014 - 8:49am
tags:
Gilead Sciences, Sovaldi, generics, hepatitis C, Cipla, Ranbaxy, Cadila, Mylan Labs, Strides Arcolab, Hetero Drugs, Sequent Scientific
Merck's Mantra On Focus Precludes An Inversion Strategy
Forbes
Monday, September 15, 2014 - 8:47am
tags:
Merck, tax inversions, Keytruda, melanoma
Sanofi aims to grow Genzyme unit with new drugs and acquisitions
Yahoo/Reuters
Sunday, September 14, 2014 - 8:43am
tags:
Sanofi, Genzyme
Pharma Boom: 14 Biosimilars To Debut In The US
Bidness
Saturday, September 13, 2014 - 11:54am
tags:
biosimilars
Keryx Biopharmaceuticals CEO Unloads $712,000 in Stock (KERX)
Sleek Money
Saturday, September 13, 2014 - 11:40am
tags:
Keryx
Echo Therapeutics Board Once Again Impedes The Rights Of Echo Stockholders
Yahoo/PR Newswire
Saturday, September 13, 2014 - 11:28am
tags:
Echo Therapeutics
Gilead to raise price for new hepatitis C drug above $84,000
Yahoo/Reuters
Friday, September 12, 2014 - 7:10pm
tags:
Gilead, Sovaldi, drug pricing, hepatitis C
FDA panel recommends approval of NPS hormone replacement drug
Yahoo/Reuters
Friday, September 12, 2014 - 7:06pm
tags:
FDA, advisory panels, NPS Pharmaceuticals, Natpara
AbbVie's Humira Positive in Phase III Skin Disease Study
Yahoo/Zacks.com
Friday, September 12, 2014 - 7:05pm
tags:
AbbVie, Humira, hidradenitis suppurativa

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.